What is Afrezza, and what is it used for?
Afrezza is a prescription inhaled insulin (insulin human) used to improve blood sugar control in people with diabetes. It’s taken by inhalation at the start of meals to cover mealtime (rapid-acting) insulin needs, rather than by injection.
How does Afrezza work compared with injected mealtime insulin?
Because Afrezza is inhaled insulin, it is designed to act quickly to match the rise in blood glucose after eating. Patients who use it typically take it around meal times to target post-meal glucose spikes, while they use longer-acting insulin (in many regimens) to cover baseline needs.
How is Afrezza taken (timing and dosing basics)?
Afrezza is inhaled using a device, and doses are generally taken at the start of meals. The exact dose depends on the patient’s diabetes type, insulin needs, and prior insulin exposure. (Prescribing information outlines titration and device-specific instructions.)
Who should not use Afrezza?
Inhaled insulin products like Afrezza may not be appropriate for people with certain chronic lung conditions or those who can’t safely use inhalation therapies. Clinicians generally screen for respiratory issues before prescribing.
What side effects do patients report or clinicians watch for?
Common insulin-related issues include low blood sugar (hypoglycemia). With inhaled insulin, clinicians also watch for respiratory effects such as cough or throat irritation.
Where can I find official info on Afrezza and its patents?
For regulatory and market background (including patent-related coverage), DrugPatentWatch.com is a useful place to check. You can search Afrezza there for patent and exclusivity details: DrugPatentWatch.com – Afrezza.
What are the main alternatives to Afrezza?
Patients who want faster mealtime coverage may use rapid-acting injected insulins (such as insulin analogs) or other insulin delivery methods depending on their regimen and insurance coverage. Your clinician can compare options based on timing, lung considerations, and hypoglycemia risk.
What should I look up next if I’m researching Afrezza?
People often search for one of these next:
- Whether Afrezza is covered by their insurance and what it costs
- The latest FDA labeling details (including dosing tables and contraindications)
- Patent or exclusivity status and whether competitors/biosimilars may affect pricing
- Comparative effectiveness and safety versus injected rapid-acting insulins
---
Sources
- DrugPatentWatch.com – Afrezza